Skip to main content
Top
Published in: Diabetologia 6/2015

01-06-2015 | Article

Upper gastrointestinal motility and symptoms in individuals with diabetes, prediabetes and normal glucose tolerance

Authors: Georgios C. Boronikolos, Björn A. Menge, Nina Schenker, Thomas G. K. Breuer, Jan-Michel Otte, Sascha Heckermann, Freimut Schliess, Juris J. Meier

Published in: Diabetologia | Issue 6/2015

Login to get access

Abstract

Aims/hypothesis

Type 2 diabetes has been associated with upper gastrointestinal motility dysfunction, but the relationship with diabetes duration and glucose control is less well understood. Gastric emptying, oesophageal motility and gastrointestinal symptoms were examined in volunteers with diabetes, prediabetes (impaired fasting glucose [IFG] or impaired glucose tolerance [IGT]) and normal glucose tolerance (NGT).

Methods

The study included 41 patients with type 2 diabetes, 17 individuals with IFG/IGT and 31 individuals with NGT. A gastric emptying breath test and high-resolution oesophageal manometry were performed. Gastrointestinal symptoms were assessed using questionnaires.

Results

Gastric emptying was delayed in individuals with IFG/IGT (p < 0.05) but was normal in the diabetic group. Amongst the diabetic patients, gastric emptying rate was fastest in those with longer diabetes duration and the highest HbA1c levels (p < 0.001). Oesophageal motility variables were similar between the groups. However, the lower oesophagus resting pressure was reduced in patients with longer diabetes duration (p = 0.01). Abdominal pain/discomfort was more frequent amongst patients with diabetes (p = 0.04) but was unrelated to gastric emptying. Significant associations between various oesophageal motility variables and gastrointestinal symptoms were observed.

Conclusions/interpretation

Gastric emptying and oesophageal motility are not generally altered in patients with type 2 diabetes. In more advanced disease stages, however, gastric emptying and oesophageal motility may be disturbed, probably as a consequence of autonomic neuropathy. Delayed gastric emptying in IFG/IGT individuals might be secondary to acute hyperglycaemia. Determination of gastric emptying and oesophageal manometry should be considered for the diagnostic workup of patients with diabetes and gastrointestinal symptoms.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sellin JH, Chang EB (2008) Therapy insight: gastrointestinal complications of diabetes—pathophysiology and management. Nat Clin Pract Gastroenterol Hepatol 5:162–171CrossRefPubMed Sellin JH, Chang EB (2008) Therapy insight: gastrointestinal complications of diabetes—pathophysiology and management. Nat Clin Pract Gastroenterol Hepatol 5:162–171CrossRefPubMed
2.
go back to reference Horowitz M, O'Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M (2002) Gastric emptying in diabetes: clinical significance and treatment. Diabet Med 19:177–194CrossRefPubMed Horowitz M, O'Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M (2002) Gastric emptying in diabetes: clinical significance and treatment. Diabet Med 19:177–194CrossRefPubMed
3.
go back to reference Horowitz M, Fraser R (1994) Disordered gastric motor function in diabetes mellitus. Diabetologia 37:543–551CrossRefPubMed Horowitz M, Fraser R (1994) Disordered gastric motor function in diabetes mellitus. Diabetologia 37:543–551CrossRefPubMed
4.
go back to reference Horowitz M, Edelbroek MA, Wishart JM, Straathof JW (1993) Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 36:857–862CrossRefPubMed Horowitz M, Edelbroek MA, Wishart JM, Straathof JW (1993) Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 36:857–862CrossRefPubMed
5.
go back to reference Moyses C, Young A, Kolterman O (1996) Modulation of gastric emptying as a therapeutic approach to glycaemic control. Diabet Med J Br Diabet Assoc 13(Suppl 5):S34–S38 Moyses C, Young A, Kolterman O (1996) Modulation of gastric emptying as a therapeutic approach to glycaemic control. Diabet Med J Br Diabet Assoc 13(Suppl 5):S34–S38
6.
go back to reference Kolterman OG, Gottlieb A, Moyses C, Colburn W (1995) Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue. Diabetes Care 18:1179–1182CrossRefPubMed Kolterman OG, Gottlieb A, Moyses C, Colburn W (1995) Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue. Diabetes Care 18:1179–1182CrossRefPubMed
7.
go back to reference Meier JJ, Gallwitz B, Salmen S et al (2003) Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. J Clin Endocrinol Metab 88:2719–2725CrossRefPubMed Meier JJ, Gallwitz B, Salmen S et al (2003) Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. J Clin Endocrinol Metab 88:2719–2725CrossRefPubMed
8.
go back to reference Meier JJ, Kemmeries G, Holst JJ, Nauck MA (2005) Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects. Diabetes 54:2212–2218CrossRefPubMed Meier JJ, Kemmeries G, Holst JJ, Nauck MA (2005) Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects. Diabetes 54:2212–2218CrossRefPubMed
9.
go back to reference Gonlachanvit S, Hsu CW, Boden GH et al (2003) Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients. Dig Dis Sci 48:488–497CrossRefPubMed Gonlachanvit S, Hsu CW, Boden GH et al (2003) Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients. Dig Dis Sci 48:488–497CrossRefPubMed
10.
go back to reference Meier JJ, Gallwitz B, Kask B et al (2004) Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects. Diabetes 53(Suppl 3):S220–S224CrossRefPubMed Meier JJ, Gallwitz B, Kask B et al (2004) Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects. Diabetes 53(Suppl 3):S220–S224CrossRefPubMed
11.
go back to reference Meier JJ, Gallwitz B, Nauck MA (2003) Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus. BioDrugs 17:93–102CrossRefPubMed Meier JJ, Gallwitz B, Nauck MA (2003) Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus. BioDrugs 17:93–102CrossRefPubMed
13.
go back to reference Nauck MA, Baller B, Meier JJ (2004) Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes. Diabetes 53(Suppl 3):S190–S196CrossRefPubMed Nauck MA, Baller B, Meier JJ (2004) Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes. Diabetes 53(Suppl 3):S190–S196CrossRefPubMed
14.
go back to reference Schvarcz E, Palmer M, Aman J, Horowitz M, Stridsberg M, Berne C (1997) Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology 113:60–66CrossRefPubMed Schvarcz E, Palmer M, Aman J, Horowitz M, Stridsberg M, Berne C (1997) Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology 113:60–66CrossRefPubMed
15.
go back to reference Vollmer K, Gardiwal H, Menge BA et al (2009) Hyperglycemia acutely lowers the postprandial excursions of glucagon-like peptide-1 and gastric inhibitory polypeptide in humans. J Clin Endocrinol Metab 94:1379–1385CrossRefPubMed Vollmer K, Gardiwal H, Menge BA et al (2009) Hyperglycemia acutely lowers the postprandial excursions of glucagon-like peptide-1 and gastric inhibitory polypeptide in humans. J Clin Endocrinol Metab 94:1379–1385CrossRefPubMed
16.
go back to reference Plummer MP, Jones KL, Annink CE et al (2014) Glucagon-like peptide 1 attenuates the acceleration of gastric emptying induced by hypoglycemia in healthy subjects. Diabetes Care 37:1509–1515CrossRefPubMed Plummer MP, Jones KL, Annink CE et al (2014) Glucagon-like peptide 1 attenuates the acceleration of gastric emptying induced by hypoglycemia in healthy subjects. Diabetes Care 37:1509–1515CrossRefPubMed
17.
go back to reference Schwartz JG, Green GM, Guan D, McMahan CA, Phillips WT (1996) Rapid gastric emptying of a solid pancake meal in type II diabetic patients. Diabetes Care 19:468–471CrossRefPubMed Schwartz JG, Green GM, Guan D, McMahan CA, Phillips WT (1996) Rapid gastric emptying of a solid pancake meal in type II diabetic patients. Diabetes Care 19:468–471CrossRefPubMed
18.
go back to reference Ziegler D, Schadewaldt P, Pour Mirza A et al (1996) [13C]Octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia 39:823–830 Ziegler D, Schadewaldt P, Pour Mirza A et al (1996) [13C]Octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia 39:823–830
19.
go back to reference Lehmann R, Borovicka J, Kunz P et al (1996) Evaluation of delayed gastric emptying in diabetic patients with autonomic neuropathy by a new magnetic resonance imaging technique and radio-opaque markers. Diabetes Care 19:1075–1082CrossRefPubMed Lehmann R, Borovicka J, Kunz P et al (1996) Evaluation of delayed gastric emptying in diabetic patients with autonomic neuropathy by a new magnetic resonance imaging technique and radio-opaque markers. Diabetes Care 19:1075–1082CrossRefPubMed
20.
go back to reference Bertin E, Schneider N, Abdelli N et al (2001) Gastric emptying is accelerated in obese type 2 diabetic patients without autonomic neuropathy. Diabetes Metab 27:357–364PubMed Bertin E, Schneider N, Abdelli N et al (2001) Gastric emptying is accelerated in obese type 2 diabetic patients without autonomic neuropathy. Diabetes Metab 27:357–364PubMed
21.
go back to reference Kong MF, Macdonald IA, Tattersall RB (1996) Gastric emptying in diabetes. Diabet Med J Br Diabet Assoc 13:112–119CrossRef Kong MF, Macdonald IA, Tattersall RB (1996) Gastric emptying in diabetes. Diabet Med J Br Diabet Assoc 13:112–119CrossRef
22.
go back to reference Faraj J, Melander O, Sundkvist G et al (2007) Oesophageal dysmotility, delayed gastric emptying and gastrointestinal symptoms in patients with diabetes mellitus. Diabet Med J Br Diabet Assoc 24:1235–1239CrossRef Faraj J, Melander O, Sundkvist G et al (2007) Oesophageal dysmotility, delayed gastric emptying and gastrointestinal symptoms in patients with diabetes mellitus. Diabet Med J Br Diabet Assoc 24:1235–1239CrossRef
23.
24.
go back to reference Annese V, Bassotti G, Caruso N et al (1999) Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol 29:171–177CrossRefPubMed Annese V, Bassotti G, Caruso N et al (1999) Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol 29:171–177CrossRefPubMed
25.
go back to reference Jorge JX, Panao EA, Simoes MA et al (2012) Esophageal body motility in people with diabetes: comparison with non-diabetic healthy individuals. Diabetes Res Clin Pract 97:77–81CrossRefPubMed Jorge JX, Panao EA, Simoes MA et al (2012) Esophageal body motility in people with diabetes: comparison with non-diabetic healthy individuals. Diabetes Res Clin Pract 97:77–81CrossRefPubMed
26.
go back to reference Ohlsson B, Melander O, Thorsson O, Olsson R, Ekberg O, Sundkvist G (2006) Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasis. Diabetologia 49:2010–2014CrossRefPubMed Ohlsson B, Melander O, Thorsson O, Olsson R, Ekberg O, Sundkvist G (2006) Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasis. Diabetologia 49:2010–2014CrossRefPubMed
27.
go back to reference Genuth S, Alberti KGMM, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167CrossRefPubMed Genuth S, Alberti KGMM, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167CrossRefPubMed
28.
go back to reference Quan C, Talley NJ, Cross S et al (2003) Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther 17:1179–1187CrossRefPubMed Quan C, Talley NJ, Cross S et al (2003) Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther 17:1179–1187CrossRefPubMed
29.
go back to reference Revicki DA, Rentz AM, Dubois D et al (2004) Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res Int J Qual Life Asp Treat Care Rehab 13:833–844CrossRef Revicki DA, Rentz AM, Dubois D et al (2004) Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res Int J Qual Life Asp Treat Care Rehab 13:833–844CrossRef
30.
go back to reference Chang J, Rayner CK, Jones KL, Horowitz M (2011) Diabetic gastroparesis—backwards and forwards. J Gastroenterol Hepatol 26(Suppl 1):46–57CrossRefPubMed Chang J, Rayner CK, Jones KL, Horowitz M (2011) Diabetic gastroparesis—backwards and forwards. J Gastroenterol Hepatol 26(Suppl 1):46–57CrossRefPubMed
31.
go back to reference Iyer PG, Borah BJ, Heien HC, Das A, Cooper GS, Chak A (2013) Association of Barrett's esophagus with type II diabetes mellitus: results from a large population-based case–control study. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 11:1108–1114 Iyer PG, Borah BJ, Heien HC, Das A, Cooper GS, Chak A (2013) Association of Barrett's esophagus with type II diabetes mellitus: results from a large population-based case–control study. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 11:1108–1114
32.
go back to reference Murray FE, Lombard MG, Ashe J et al (1987) Esophageal function in diabetes mellitus with special reference to acid studies and relationship to peripheral neuropathy. Am J Gastroenterol 82:840–843PubMed Murray FE, Lombard MG, Ashe J et al (1987) Esophageal function in diabetes mellitus with special reference to acid studies and relationship to peripheral neuropathy. Am J Gastroenterol 82:840–843PubMed
33.
go back to reference Zhang Q, Horowitz M, Rigda R, Rayner C, Worynski A, Holloway RH (2004) Effect of hyperglycemia on triggering of transient lower esophageal sphincter relaxations. Am J Physiol Gastrointest Liver Physiol 286:G797–G803CrossRefPubMed Zhang Q, Horowitz M, Rigda R, Rayner C, Worynski A, Holloway RH (2004) Effect of hyperglycemia on triggering of transient lower esophageal sphincter relaxations. Am J Physiol Gastrointest Liver Physiol 286:G797–G803CrossRefPubMed
34.
go back to reference Boeckxstaens GE, Horowitz M, Bermingham H, Holloway RH (1997) Physiological variations in blood glucose concentration affect oesophageal motility and sensation in normal subjects. Neurogastroenterol Motil 9:239–246CrossRefPubMed Boeckxstaens GE, Horowitz M, Bermingham H, Holloway RH (1997) Physiological variations in blood glucose concentration affect oesophageal motility and sensation in normal subjects. Neurogastroenterol Motil 9:239–246CrossRefPubMed
35.
go back to reference Quan C, Talley NJ, Jones MP, Howell S, Horowitz M (2008) Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol 20:888–897CrossRefPubMed Quan C, Talley NJ, Jones MP, Howell S, Horowitz M (2008) Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol 20:888–897CrossRefPubMed
36.
go back to reference Quan C, Talley NJ, Jones MP, Spies J, Horowitz M (2008) Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up. Am J Gastroenterol 103:2023–2030CrossRefPubMed Quan C, Talley NJ, Jones MP, Spies J, Horowitz M (2008) Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up. Am J Gastroenterol 103:2023–2030CrossRefPubMed
37.
go back to reference Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW (2013) Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med 368:1613–1624 Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW (2013) Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med 368:1613–1624
38.
go back to reference Saaddine JB, Cadwell B, Gregg EW et al (2006) Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002. Ann Intern Med 144:465–474 Saaddine JB, Cadwell B, Gregg EW et al (2006) Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002. Ann Intern Med 144:465–474
Metadata
Title
Upper gastrointestinal motility and symptoms in individuals with diabetes, prediabetes and normal glucose tolerance
Authors
Georgios C. Boronikolos
Björn A. Menge
Nina Schenker
Thomas G. K. Breuer
Jan-Michel Otte
Sascha Heckermann
Freimut Schliess
Juris J. Meier
Publication date
01-06-2015
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 6/2015
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3538-3

Other articles of this Issue 6/2015

Diabetologia 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.